Liangfu Xu

2 articles listing Liangfu Xu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Targeting m6A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo Nature Communications
2. Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial Nature Communications